Monoklonale Antikörper bei Multipler Sklerose : Therapie mit monoklonalen Antikörpern: aktueller Stand und Perspektiven = Therapy with monoclonal antibodies: Current status and perspectivesGOLD, Ralf.Arzneimittel-Forschung. 2005, Vol 55, Num 11, pp 702-703, issn 0004-4172, 2 p.Conference Paper

Oral Therapies for Multiple Sclerosis: A Review of Agents in Phase III Development or Recently ApprovedGOLD, Ralf.CNS drugs. 2011, Vol 25, Num 1, pp 37-52, issn 1172-7047, 16 p.Article

Mode of action and clinical studies with fumarates in multiple sclerosisSALMEN, Anke; GOLD, Ralf.Experimental neurology (Print). 2014, Vol 262, pp 52-56, issn 0014-4886, 5 p., aArticle

Review of laquinimod and its therapeutic potential in multiple sclerosisTHÖNE, Jan; GOLD, Ralf.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 18, pp 2545-2552, issn 1465-6566, 8 p.Article

Progressive multifocal leukoencephalopathy and natalizumabHELLWIG, Kerstin; GOLD, Ralf.Journal of neurology. 2011, Vol 258, Num 11, pp 1920-1928, issn 0340-5354, 9 p.Article

Multiple sclerosis therapy : new agents carry new risksGOLD, Ralf; HOHLFELD, Reinhard.Practical neurology (Print). 2006, Vol 6, Num 4, pp 248-251, issn 1474-7758, 4 p.Article

Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitisHOFSTETTER, Harald H; TOYKA, Klaus V; GOLD, Ralf et al.Neuroscience letters. 2005, Vol 391, Num 3, pp 127-130, issn 0304-3940, 4 p.Article

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatmentHELLWIG, Kerstin; HAGHIKIA, Aiden; GOLD, Ralf et al.Multiple sclerosis. 2011, Vol 17, Num 8, pp 958-963, issn 1352-4585, 6 p.Article

Parenthood and immunomodulation in patients with multiple sclerosisHELLWIG, Kerstin; HAGHIKIA, Aiden; GOLD, Ralf et al.Journal of neurology. 2010, Vol 257, Num 4, pp 580-583, issn 0340-5354, 4 p.Article

Assessment of lesion evolution in experimental autoimmune neuritis by gadofluorine M-enhanced MR neurographySTOLL, Guido; WESSIG, Carsten; GOLD, Ralf et al.Experimental neurology (Print). 2006, Vol 197, Num 1, pp 150-156, issn 0014-4886, 7 p.Article

The pathogenesis of CIDP: Rationale for treatment with immunomodulatory agentsTOYKA, Klaus V; GOLD, Ralf.Neurology. 2003, Vol 60, Num 8, pp S2-S7, issn 0028-3878, SUP3Article

Long-term treatment of Lewis―Sumner syndrome with subcutaneous immunoglobulin infusionsBAYAS, Antonios; GOLD, Ralf; NAUMANN, Markus et al.Journal of the neurological sciences. 2013, Vol 324, Num 1-2, pp 53-56, issn 0022-510X, 4 p.Article

Mycophenolate mofetil and tacrolimus : New therapeutic options in neuroimmunological diseasesSCHNEIDER-GOLD, Christiane; HARTUNG, Hans-Peter; GOLD, Ralf et al.Muscle & nerve. 2006, Vol 34, Num 3, pp 284-291, issn 0148-639X, 8 p.Article

Understanding pathogenesis and therapy of multiple sclerosis via animal models : 70 years of merits and culprits in experimental autoimmune encephalomyelitis researchGOLD, Ralf; LININGTON, Christopher; LASSMANN, Hans et al.Brain. 2006, Vol 129, pp 1953-1971, issn 0006-8950, 19 p., 8Article

A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosisHELLWIG, Kerstin; SCHIMRIGK, Sebastian; CHAN, Andrew et al.Journal of the neurological sciences. 2011, Vol 307, Num 1-2, pp 164-165, issn 0022-510X, 2 p.Article

Anti-GT1a IgG antibodies in a child with severe Guillain-Barré syndromeSCHESSL, Joachim; FUNAKOSHI, Kei; SUSUKI, Keiichiro et al.Pediatric neurology. 2006, Vol 35, Num 4, pp 277-279, issn 0887-8994, 3 p.Article

Sonographic detection of bilateral striopallidodentate calcinosisKROGIAS, Christos; MEVES, Saskia; SCHOELLHAMMER, Martin et al.Journal of neurology. 2009, Vol 256, Num 2, pp 266-267, issn 0340-5354, 2 p.Article

Isolated ZIC4 Antibodies in Paraneoplastic Cerebellar Syndrome With an Underlying Ovarian TumorKERASNOUDIS, Antonios; ROCKHOFF, Milena; FEDERLEIN, Jens et al.Archives of neurology (Chicago). 2011, Vol 68, Num 8, pp 1073-1074, issn 0003-9942, 2 p.Article

Therapy of immune neuropathies with intravenous immunoglobulinsGOLD, Ralf; KIESEIER, Bernd C.Journal of neurology. Supplement. 2006, Vol 253, Num 5, pp 59-63, issn 0939-1517, 5 p.Conference Paper

Symptomatic hyperekplexia in a patient with multiple sclerosisRUPRECHT, Klemens; WARMUTH-METZ, Monika; WAESPE, Walter et al.Neurology. 2002, Vol 58, Num 3, pp 503-504, issn 0028-3878Article

Combination therapies in multiple sclerosisGOLD, Ralf.Journal of neurology. 2008, Vol 255, pp 51-60, issn 0340-5354, 10 p., SUP1Conference Paper

Response inhibition in Huntington's disease : A study using ERPs and sLORETABESTE, Christian; SAFT, Carsten; ANDRICH, Jurgen et al.Neuropsychologia. 2008, Vol 46, Num 5, pp 1290-1297, issn 0028-3932, 8 p.Article

Neuropsychological/-psychiatric deficits in immune-mediated neuropathiesCHAN, Andrew; GOLD, Ralf.Journal of neurology. Supplement. 2007, Vol 254, Num 2, pp 93-95, issn 0939-1517, 3 p.Conference Paper

ATYPICAL OCCIPITAL CALCINOSIS IN A CAUCASIAN INDIVIDUAL WITH PROBABLE DIFFUSE NEUROFIBRILLARY TANGLES WITH CALCIFICATIONFAISSNER, Simon; HOEPNER, Robert; ELLRICHMANN, Gisa et al.Journal of the American Geriatrics Society. 2014, Vol 62, Num 10, pp 2022-2024, issn 0002-8614, 3 p.Article

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trialGOLD, Ralf; GIOVANNONI, Gavin; ELKINS, Jacob et al.Lancet (British edition). 2013, Vol 381, Num 9884, pp 2167-2175, issn 0140-6736, 9 p.Article